AI ‘Fragle’ Method Makes Cancer Tracking More Efficient
Researchers have developed an AI blood test called Fragle to accurately and affordably track cancer treatment response and detect relapse.
Read More
Search Results for: lung cancer
Quest Diagnostics to Develop MCaST Blood Test
Quest Diagnostics is partnering with MD Anderson Cancer Center to develop a lab-based blood test for cancer that uses protein biomarkers.
Read More
Liquid Biopsy Launched at Florida Cancer Institute
Florida Cancer Specialists & Research Institute now offers liquid biopsy, a minimally invasive blood test that enhances cancer diagnosis.
Read More
Shield MCD Test Gets Breakthrough Device Designation
Guardant Health’s Shield MCD test has received FDA Breakthrough Device designation for its ability to detect multiple cancer types.
Read More
Vizgen and Hamamatsu Partner to Streamline Spatial Biology Workflows
Vizgen and Hamamatsu Photonics have partnered to integrate advanced multiplex imaging and assay technologies, streamlining workflows.
Read More